Figure. 3.
Ketamine delays the worsening of the respiratory function. (A) Representative plethysmography traces illustrating breathing pattern. (B) Quantification of the number of apneas per minute. Ketamine treatment from P30 prevented the developmental increase of apneic episodes (Wilcoxon signed-rank test, * p < 0.05, ** p ≤ 0.01. WT-v, n = 8; KO-v, n = 11; KO-k15, n = 7; KO-k30, n = 8 mice).